Sfoglia per AUTORE
LOREFICE L
Collezione AOU San Luigi di Orbassano

  

Items : 8

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.

2024
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Di Sabatino E; Clerico M; Guaschino C; Radaelli M; Fantozzi R; Buttari F; Laroni A; Gajofatto A; Calabrese M; Malucchi S; Paolicelli D; De Luca G; Tomassini V; Lanzillo R; Moccia M; Solaro C; Cocco E; Gasperini C; Tortorella C; Maniscalco GT; Gallo A; Cavalla P; Lorefice L; Nociti V; Prosperini L; Di Filippo M; Ferraro D; Ragonese P;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.

2022
AOU San Luigi di Orbassano

Rasia S; Salemi G; Signoriello E; Vitetta F; Totaro R; Sormani MP; Amato MP; Marfia GA; Malucchi S; Margoni M; Mataluni G; Mirabella M; Moiola L; Nicoletti CG; Nociti V; Patti F; Pinardi F; Portaccio E; Pozzilli C; Ragonese P; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; Ferraro E; Gallo A; Gasperini C; Granella F; et alii...

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug

2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Gasperini C; Gallo A; Solaro C; Tortorella C; Gazzola P; Cocco E; Paolicelli D; Maniscalco GT; Borrelli A; Calabrese M; Tomassini V; De Luca G; Boffa L; Lanzillo R; Moccia M; Clerico M; Fantozzi R; Prosperini L; Gajofatto A; Lorefice L; Ferraro D; Laroni A; Buttari F; Nociti V; Radaelli M; Ragonese P; Cavalla P; Torri Clerici V; Annovazzi P; et alii...

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Torino 4

Clerico M; Sormani MP; Capra R; Costantini G; Cavalla P; Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Curti E; Maniscalco GT; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Signori A; Cordioli C; De Mercanti SF;

Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Oct;45:102394. doi: 10.1016/j.msard.2020.102394. Epub 2020 Jul 12.

2020
AOU San Luigi di Orbassano
ASL Vercelli

Tomassini V; Ragonese P; Radaelli M; Prosperini L; Pinardi F; Paolicelli D; Nociti V; Mallucchi S; Lorefice L; Laroni A; Lanzillo R; Gallo A; Gajofatto A; Di Filippo M; Ferraro D; Cordioli C; Cavalla P; Calabrese M; Buscarinu MC; Annovazzi P; Moccia M; Tortorella C; Cocco E; Gasperini C; Solaro C;

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.

2020
AOU San Luigi di Orbassano
ASL Cuneo 1

Abbadessa G; Barilaro A; Fenu G; Brescia Morra V; Sperli F; Prestipino E; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Sacco R; Gallo A; Salemi G; Mechi C; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Maniscalco GT; Barone S; Signoriello E; Di Sapio A; Cavalla P; Mataluni G; Brambilla L; Curti E; et alii...

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2020 Jan;17(1):200-207. doi: 10.1007/s13311-019-00776-7.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Torino 4

Costantini G; Sormani MP; Cavalla P; Sartori A; Laroni A; Frangiamore R; Gandoglia I; Petruzzo M; Lanzillo R; Mataluni G; Landi D; Mirabella M; Baroncini D; Nociti V; Cocco E; Lorefice L; Curti E; Bonavita S; Lavorgna L; Maniscalco GT; Signoriello E; Lus G; Cordioli C; Signori A; Iudicello M; Capra R; De Mercanti SF; Clerico M;

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.

2019
AOU San Luigi di Orbassano

Scarpini E; Costantino G; Scandellari C; Righini I; Bellantonio P; Amato MP; Milani N; Miante S; Gallo P; Margoni M; Capobianco M; Bertolotto A; D'Amico E; Patti F; Fanelli F; Simone M; Iaffaldano P; Fenu G; Lorefice L; Moiola L; Zaffaroni M; Baroncini D; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;